CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 45 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,744,000 | +141.5% | 110,787 | +67.2% | 0.00% | +100.0% |
| Q1 2021 | $1,550,000 | -46.5% | 66,271 | -34.1% | 0.00% | -50.0% |
| Q4 2020 | $2,896,000 | +36.8% | 100,573 | -3.8% | 0.00% | +100.0% |
| Q3 2020 | $2,117,000 | +84.4% | 104,493 | +173.7% | 0.00% | 0.0% |
| Q2 2020 | $1,148,000 | +37.0% | 38,176 | +43.1% | 0.00% | 0.0% |
| Q1 2020 | $838,000 | -2.9% | 26,682 | +45.5% | 0.00% | – |
| Q4 2019 | $863,000 | +1626.0% | 18,336 | +137.5% | 0.00% | – |
| Q3 2019 | $50,000 | -59.3% | 7,720 | -23.3% | 0.00% | – |
| Q2 2019 | $123,000 | +101.6% | 10,066 | +124.9% | 0.00% | – |
| Q1 2019 | $61,000 | +510.0% | 4,476 | +196.0% | 0.00% | – |
| Q3 2018 | $10,000 | – | 1,512 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |